To determine the impact of antibody treatment on the pathways downstream the EphA2 receptor in vivo, we determined the level of expression and phosphorylation of Akt, Erk, and FAK in tumor lysates from control and treated mice. This evidence concerns the gene MAPK1 and neoplasm.